NCT05391061View on ClinicalTrials.gov

A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis

RecruitingOBSERVATIONAL

Enrollment

1,100

Participants

Timeline

Start Date

January 7, 2023

Primary Completion Date

November 22, 2027

Study Completion Date

November 22, 2027

Conditions

Dermatitis, Atopic

Interventions

DRUG

Abrocitinib

Tablets

Trial Locations (1)

04631

RECRUITING

Pfizer Tower, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY